Home › Amyloidosis › Georgia › Atlanta
Amyloidosis clinical trials in Atlanta, GA
3 studies for Amyloidosis are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RecruitingPhase 3
- Emory University School of Medicine, Atlanta
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
RecruitingPhase 3
- Clinical Trial Site, Atlanta
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- Emory University School of Medicine, Atlanta
About Amyloidosis
Amyloidosis is a rare condition that can affect different organs of the body. Find out about amyloidosis treatment and symptoms.
More about Amyloidosis on MedlinePlus
Amyloidosis trials in other cities
- Boston, MA12 studies
- Rochester, MN10 studies
- New York City, NY10 studies
- Dallas, TX9 studies
- Philadelphia, PA7 studies
- Baltimore, MD6 studies
- Houston, TX6 studies
- San Diego, CA6 studies
- Durham, NC6 studies
- Nashville, TN6 studies
- Portland, OR6 studies
- St. Louis, MO6 studies
Other studies in Atlanta
- Cancer (all types)49 studies
- Non-Small Cell Lung Cancer48 studies
- Multiple Myeloma42 studies
- Breast Cancer42 studies
- Prostate Cancer36 studies
- Acute Myeloid Leukemia30 studies
- Metastatic Cancer29 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Lung Cancer28 studies
- Obesity26 studies
- Major Depressive Disorder24 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.